Tag: Dr Christian Behrenbruch
Telix to acquire RLS in major expansion of North American manufacturing and distribution platform
Telix Pharmaceuticals announced its agreement to acquire RLS (USA) Inc, the only Joint Commission-accredited radiopharmacy network in the US, as part of a strategic move to expand its North American manufacturing and distribution capabilities.
Telix ventures into advanced isotope production with ARTMS acquisition
Telix Pharmaceuticals Limited has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc, its advanced cyclotron-based isotope production platform, manufacturing plant, and stockpile of ultra-pure rare metals required for consumable target production.
Telix Pharmaceuticals expands US manufacturing ops with IsoTherapeutics acquisition
Telix Pharmaceuticals Limited announced its agreement to acquire IsoTherapeutics Group, a specialty radiopharmaceutical development and bioconjugation firm headquartered in Angleton, Texas.
Featured Article
Driving the future of smart energy: GridBeyond and ABB unveil new white paper on battery storage innovation
As industries adopt cleaner, more intelligent energy solutions, the ability to manage, store, and trade energy efficiently is increasingly vital to sustaining a competitive edge.
